The hypoxia-activated prodrug evofosfamide in combination with multiple regimens of radiotherapy

The promising treatment combination of ionizing radiation (IR) with a hypoxia-activated prodrug (HAP) is based on biological cooperation. Here we investigated the hypoxia-activated prodrug evofosfamide in combination with different treatment regimens of IR against lung A549- and head&neck UT-SCC...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncotarget
Prif Awduron: Nytko, Katarzyna J., Grgic, Ivo, Bender, Sabine, Ott, Janosch, Guckenberger, Matthias, Riesterer, Oliver, Pruschy, Martin
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Impact Journals LLC 2017
Pynciau:
Research Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5410338/
https://ncbi.nlm.nih.gov/pubmed/28423594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15784
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg